Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1DPO
|
||||
Drug Name |
SID14739111
|
||||
Synonyms |
CHEMBL1603702
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C19H22N2O3
|
||||
Canonical SMILES |
COc1ccc(NC(=O)C(NC(=O)c2ccccc2)C(C)C)cc1
|
||||
InChI |
InChI=1S/C19H22N2O3/c1-13(2)17(21-18(22)14-7-5-4-6-8-14)19(23)20-15-9-11-16(24-3)12-10-15/h4-13,17H,1-3H3,(H,20,23)(H,21,22)
|
||||
InChIKey |
YSCUVMZQMPFKMA-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.